The Commission on Combatting Drug Addiction and the Opioid Crisis appointed by President Trump released its report on Monday, July 31. Drug policy fellow Katharine Neill Harris assesses the commission's recommendations in the Baker Institute Blog.
Drug policy fellow Katharine A. Neill explains why establishing heroin-assisted treatment programs, which provide severely addicted individuals with controlled access to pharmaceutical-grade heroin, could make a significant dent in the number of U.S. deaths from opioid use in this post for the Baker Institute Blog.
James A. Baker, III, and George P. Shultz — both former secretaries of state and Treasury secretaries — offer "A Conservative Answer to Climate Change" in a commentary for The Wall Street Journal.
James A. Baker, III, George P. ShulzFebruary 15, 2017
Understood in its regional context, Philippines President Rodrigo Duterte’s war on drugs appears to be a continuation rather than a departure from Southeast Asian drug policy.
In this blog post, Mexico Center director Tony Payan discusses the results of Mexico's June 5 election and what they mean for the country's 2018 presidential election.
While Mexico may indeed emerge from the recent oil price slump in better shape than most, tinkering with the solid macroeconomic foundations established by the country’s last three administrations could lead to trouble.
High cancer drug prices reduce access to therapy, cause treatment abandonment and financial bankruptcies, as well as severe emotional and family distress.
Baker Institute experts explain how Friday's arrest of Mexican drug lord Joaquin "El Chapo" Guzman will affect the Peña Nieto administration, the Sinaloa Cartel and the Mexican government's "kingpin strategy" to destroy the cartels.
Tony Payan, Gary J. Hale, Nathan P. JonesJanuary 9, 2016